Imagine
The potential of medical innovation is limitless. If Europe fully seizes this opportunity, just imagine what we could achieve
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 28.04.25
Unmet medical needs in chronic cardiovascular diseases: Innovative approaches to therapeutic adherence...
A narrow definition of unmet medical need overlooks the potential of existing medicines to improve outcomes for patients
Read Article -
Statements & press releases 25.04.25
New research shows voucher system to drive R&D in antimicrobial resistance (AMR) is 45% less expensive...
Antimicrobial resistance (AMR) is one of the world’s most pressing health emergencies. Yet despite the urgent need, private investment in antimicrobial...
Read Article -
Statements & press releases 17.04.25
A Strategy for European Life Sciences
EFPIA welcomes the Commission initiative to develop a robust EU Life Sciences Strategy to strengthen Europe competitiveness and close the innovation gap...
Read Article -
External Event 13.05.25
International conference on protein stability
The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial interest in the reality and impact...
View Event -
External Event 20.05.25
EU Pharmaceutical Law Forum
Engage with the influencers shaping European pharmaceutical law.
View Event -
External Event 03.06.25
JLABS | Paths to the patient: Business models for drug discovery and development
How do you choose the right path to bring your drug discovery to patients? Join this JLABS program to discover the pros and cons.
View Event
Featured Articles
